Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q2 2025 · 10-Q
Revenue$0.00$0.00−100.0% vs Q2 2024 Net Income-$2.05M-$2.05MN/M vs Q2 2024 EPS Diluted-$0.40-$0.40no prior Q2 2024 on file Operating Income-$2,051,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,650,000N/M ended Jun 30, 2025 · filed Aug 11, 2025 · 42 d after period end